Addressing Problems in Managing Daily Tasks Due to Poststroke Cognitive Impairments
Launched by EMMA GHAZIANI · Apr 24, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how to help people who have had a stroke manage everyday tasks better when they experience mild to moderate cognitive impairments. Cognitive impairments can make it hard for someone to think clearly or remember things, which can affect their ability to perform daily activities, like cooking or managing finances. The study aims to figure out how to create effective support and rehabilitation programs for these individuals, focusing on their specific needs and challenges.
To be eligible for this trial, participants must be at least 18 years old, have experienced their first stroke, and live independently before the stroke. They should also still have some difficulties with daily tasks due to cognitive issues after being discharged from the hospital. Caregivers can join the trial if they are closely involved with the patient and can give their consent. Participants can expect to engage in tailored rehabilitation activities designed to improve their daily functioning and cognitive skills. This study is currently recruiting participants in Frederiksberg Municipality, Denmark, and aims to better understand how to support stroke survivors in their daily lives.
Gender
ALL
Eligibility criteria
- PATIENTS:
- Inclusion criteria:
- • first-ever symptomatic stroke,
- • age ≥ 18 years,
- • residence in Frederiksberg Municipality, Denmark,
- • independent in pre-stroke everyday life (≤ 2 points on the modified Rankin Scale, mRS),
- • experiencing problems in performing ADLs due to cognitive impairment; these problems are expected to still be present at hospital discharge,
- • medical condition allows commencement of rehabilitation focused on ADL and cognition
- • fully aware or mild-to-moderate unawareness of deficits (≤ 2 points on the Bisiach Anosognosia Scale, BAS),
- • a global cognitive function corresponding to ≥ 17 points on the Montreal Cognitive Assessment, MoCA,
- • ≤ 10 points on the depression subscale of the Hospital Anxiety and Depression Scale, HADS,
- • able to provide informed consent, as evaluated by the recruiting healthcare professional(s),
- • logistically possible to perform baseline assessments and create an individualised intervention plan during hospital stay
- • provides informed consent
- Exclusion criteria:
- • psychiatric conditions causing difficulties or preventing participation, as evaluated by the recruiting health care professional(s)
- • communication problems causing difficulties or preventing participation, as evaluated by the recruiting healthcare professional(s)
- CAREGIVERS:
- Inclusion criteria:
- • appointed as close carer (by a patient who consented to participate),
- • age ≥18y,
- • provides informed consent.
- Exclusion criteria:
- • -communication problems or other issues causing difficulties in participation as evaluated by the recruiting healthcare professional(s).
- • Patients without a close carer will not be excluded.
- CLINICAL STAFF:
- Inclusion criteria:
- • appointed as local project managers, or OTs or NPs who conduct assessments or deliver the intervention in the participating centres,
- • provides informed consent.
- Exclusion criteria:
- • - unable to to follow a preliminary English version of the intervention manual.
About Emma Ghaziani
Emma Ghaziani is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and methodologies, Ghaziani leads the development and management of clinical trials that adhere to the highest ethical and regulatory standards. Her expertise spans various therapeutic areas, ensuring that each trial not only meets rigorous scientific criteria but also prioritizes participant safety and well-being. By fostering collaboration among researchers, healthcare professionals, and stakeholders, Emma Ghaziani plays a pivotal role in the translation of groundbreaking discoveries into effective treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Frederiksberg, , Denmark
Frederiksberg, , Denmark
Frederiksberg, , Denmark
Patients applied
Trial Officials
Hanne Christensen, Professor
Principal Investigator
Bispebjerg and Frederiksberg Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported